Therapeutic recommendations and seasonal influenza vaccine for multiple sclerosis patients in treatment with ocrelizumab: an expert consensus

被引：0
|
作者：
Massimo Filippi
Ruggero Capra
Diego Centonze
Claudio Gasperini
Francesco Patti
Paola Perini
Carlo Pozzilli
Maria A. Rocca
Antonio Uccelli
Maria Trojano
机构：
[1] IRCCS San Raffaele Scientific Institute,Neurology Unit, MS Center
[2] IRCCS San Raffaele Scientific Institute,Neurorehabilitation Unit
[3] IRCCS San Raffaele Scientific Institute,Neurophysiology Service
[4] IRCCS San Raffaele Scientific Institute,Neuroimaging Research Unit, Division of Neuroscience
[5] Vita-Salute San Raffaele University,Multiple Sclerosis Center
[6] Spedali Civili of Brescia,Department of Systems Medicine
[7] Tor Vergata University,Unit of Neurology
[8] IRCCS Neuromed,Department of Neurosciences
[9] San Camillo Forlanini Hospital,Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia
[10] University of Catania,Multiple Sclerosis Center, PO G Rodolico
[11] University of Catania,Multiple Sclerosis Centre of the Veneto Region, Neurology Clinic, Department of Neurosciences (DNS)
[12] University of Padua,Multiple Sclerosis Center
[13] ‘S. Andrea’ Hospital,Department of Neurology, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI)
[14] University of Genoa,Neurology and Neurophysiopathology Unit, Department of Basic Medical Sciences, Neuroscience and Sense Organs
[15] University of Bari “Aldo Moro”,undefined
来源：
Journal of Neurology | 2021年 / 268卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1540 / 1543
页数：3
相关论文
共 50 条
  • [21] Different Treatment Outcomes of Multiple Sclerosis Patients Receiving Ocrelizumab or Ofatumumab
    Meuth, Sven G.
    Wolff, Stephanie
    Mueck, Anna
    Willison, Alice
    Kleinschnitz, Konstanze
    Raeuber, Saskia
    Pawlitzki, Marc
    Konen, Franz Felix
    Skripuletz, Thomas
    Grothe, Matthias
    Ruck, Tobias
    Huttner, Hagen B.
    Kleinschnitz, Christoph
    Bopp, Tobias
    Pul, Refik
    Cree, Bruce A. C.
    Hartung, Hans-Peter
    Moellenhoff, Kathrin
    Pfeuffer, Steffen
    ANNALS OF NEUROLOGY, 2024,
  • [22] Immune response to seasonal influenza vaccine in patients with relapsing-remitting multiple sclerosis on long-term daclizumab HYP treatment
    Mehta, L.
    Priestley, R.
    Umans, K.
    Ozen, G.
    Robinson, R.
    Sweetser, M.
    Elkins, J.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 234 - 235
  • [23] Austrian consensus recommendations for the treatment of patients with multiple myeloma
    E. Gunsilius
    Johannes Drach
    memo - Magazine of European Medical Oncology, 2010, 3 (1) : 7 - 10
  • [24] Austrian consensus recommendations for the treatment of patients with multiple myeloma
    Gunsilius, E.
    Drach, J.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2010, 3 (01) : 7 - 10
  • [25] Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis
    Maria Cellerino
    Giacomo Boffa
    Caterina Lapucci
    Francesco Tazza
    Elvira Sbragia
    Elisabetta Mancuso
    Nicolò Bruschi
    Simona Minguzzi
    Federico Ivaldi
    Ilaria Poirè
    Alice Laroni
    Gianluigi Mancardi
    Elisabetta Capello
    Antonio Uccelli
    Giovanni Novi
    Matilde Inglese
    Neurotherapeutics, 2021, 18 : 2579 - 2588
  • [26] Effectiveness and safety of ocrelizumab in patients with multiple sclerosis
    Madrid-Paredes, A.
    Alvarez-Sanchez, R.
    Nieto-Gomez, P.
    Portillo-Haro, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 287 - 287
  • [27] Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis
    Cellerino, Maria
    Boffa, Giacomo
    Lapucci, Caterina
    Tazza, Francesco
    Sbragia, Elvira
    Mancuso, Elisabetta
    Bruschi, Nicolo
    Minguzzi, Simona
    Ivaldi, Federico
    Poire, Ilaria
    Laroni, Alice
    Mancardi, Gianluigi
    Capello, Elisabetta
    Uccelli, Antonio
    Novi, Giovanni
    Inglese, Matilde
    NEUROTHERAPEUTICS, 2021, 18 (04) : 2579 - 2588
  • [28] Predictors of ocrelizumab effectiveness in patients with multiple sclerosis
    Cellerino, Maria
    Boffa, Giacomo
    Lapucci, Caterina
    Tazza, Francesco
    Sbragia, Elvira
    Mancuso, Elisabetta
    Bruschi, Nicolo
    Minguzzi, Simona
    Ivaldi, Federico
    Poire, Ilaria
    Laroni, Alice
    Mancardi, Gian Luigi
    Capello, Elisabetta
    Uccelli, Antonio
    Novi, Giovanni
    Inglese, Matilde
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [29] Current therapeutic recommendations in multiple sclerosis
    Berger, Thomas
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 287 : S37 - S45
  • [30] Cost-effectiveness of ocrelizumab for treatment of Iranian patients with relapsing multiple sclerosis
    Ayati, Nayyereh
    Taheri, Saeed
    Sahraian, Mohammad Ali
    Nikfar, Shekoufeh
    CURRENT JOURNAL OF NEUROLOGY, 2021, 20 (03): : 154 - 161
12345